Table 1.
Baseline characteristics between groups
| CT (P25–P75) | LV (P25–P75) | HV (P25–P75) | p groups | |
|---|---|---|---|---|
| Age (years) | 60.0 (54.0–64.5) | 62.0 (58.0–68.0) | 62.0 (54.7–65.5) | 0.283 |
| BMI (kg m−2) | 32.4 (25.2–33.6) | 27.8 (27.5–29.4) | 27.4 (23.3–33.7) | 0.647 |
| E2 (pg/ml) | 5.0 (5.0–10.4) | 5.0 (5.0–5.14) | 6.8 (5.0–12.1) | 0.635 |
| FSH (mUI/ml) | 62.0 (58.7–73.5) | 85.0 (60.1–115.4) | 79.9 (60.4–93.1) | 0.274 |
| T4 (ng/dl) | 1.0 (1.0–1.3) | 1.1 (1.0–1.2) | 1.0 (1.0–1.1) | 0.930 |
| TSH (mUI/L) | 2.8 (1.8–4.4) | 2.4 (1.0–2.8) | 3.2 (1.7–4.6) | 0.281 |
Data are presented in median and interquartile range (P25–P75)
CT control group, LV low-volume group, HV high-volume group, BMI body mass index, E 2 estradiol, FSH follicle-stimulating hormone, T4 free tiroxin, TSH thyroid-stimulating hormone